Articles On BOD Australia (ASX:BDA)

What's happened? Bod Australia Limited (“Bod", ASX: BDA) has received an import licence for two new medical cannabis products. What are the details? The new products expand the offering to now include a CBD isolate in 2.5% and 10% strengths...

The cannabis industry has come a long way in recent years but the legal framework remains murky. The primary issue is the industry’s overall status. Cannabis can be legally grown for medical and scientific purposes but it is illegal for per...

Quarterly reports for biotechs usually only tell investors how much cash they have left — and how much time they have until the next cap raise. But December quarterlies from late Friday and today include several companies that are making mo...

What's happened? BOD Australia Limited (ASX: BDA, ‘Bod Australia’) released their quarterly activities and cashflow report for Q2 FY2019/2020. What are the highlights? BOD Australia confirmed sales for Q2 FY 2019/2020 of $536,000, which is...

Marijuana is the hottest herb on the planet right now, but while investing in medical cannabis stocks could make you a fortune, it could also risk the house. After a flurry of activity on the ASX in 2017 as the sector kicked off following l...

When Canberra became the first Australian jurisdiction to legalise cannabis in September it was the bud for many companies to stem out into a fast growing industry. Throughout the latter half of 2019, many CBD-focused companies took adv...

Defensive Stocks The entities whose earnings growth and performance have a very low association to the economy are known as defensive stocks. The revenue, cash flow etc of defensive stocks continue to be steady irrespective of the economy....

What's Happened Bod Australia Limited ("Bod", ASX: BDA) has successfully launched its first CBD products to market in the UK. Products are now live in the United Kingdom under new premium brand CBII (www.cbii-cbd.com). This is part of the C...

The cannabis sector globally is defined in part by its multi-speed regulatory backdrop. For example, THC products are legalised at the federal level in Canada, but not the US (or Australia). US lawmakers did pass the Farm bill last December...

Cannabis remains to be a subject of high speculation across the globe, even though significant advancement has been made in this field. A topic of taboo once, cannabis currently is one of the most discussed business opportunities globally,...

What's New? Bod Australia (ASX: BDA) has streamlined its board and management team. This includes the appointment of Mr. Mark Masterson as Non-Executive Chairman. Who is Mr. Masterson? Mr Masterson boasts two decades of experience in the ph...

Defensive Stocks Investors avoid volatility when it comes to the stock returns, more so when we take retail investors into consideration. Equity returns by their very intrinsic nature provide volatile returns, does that mean there is no so...

It certainly has been a busy day for the local cannabis industry. A large number of announcements have been made by Australian pot stocks today. Here’s a summary of what’s happening: The BOD Australia Ltd (ASX: BDA) share price is up over...

Project Twenty21 will be Europe’s largest study on the effects of cannabis in patients with chronic conditions and Bod Australia (ASX:BDA) will be a part of it. The cannabis small cap is one of five companies invited to participate in the p...

What's happened? Bod Australia Limited (“Bod”, the “Company”) (ASX: BDA), will be participating in Project Twenty21, Europe’s largest medicinal cannabis project, which will study the effects of cannabis when used on patients with chronic co...

2018 witnessed several catalysts for the legal cannabis industry, with countries legalising medicinal cannabis, public and private sector getting into constructive discussions about the calibre and cons of the pot industry from a business p...

It has been a busy day in the Australian cannabis industry with a series of an announcements being made this morning. Here’s what has been happening today: BOD Australia Ltd (ASX: BDA) This morning this medicinal cannabis healthcare produc...

Note: This is a re-publication, with permission, of a newspaper column that was originally published on 14 Sep 2019. The genuine investor interest behind the fake meat trend By Tim Boreham, Editor, The New Criterion Meat substitute stocks a...

Cannabis was once synonymous with drugs, marijuana, ill-health and the scourges of our society. Presently, cannabis is associated with medication, business and legalisation. This proves that we have come a long way in the cannabis space, an...

Australian medicinal cannabis company Bod (ASX: BDA) has seen sales of its MediCabilis product soar during August. The company dispensed 329 MediCabilis prescriptions in August, representing an increase of 95 per cent from July 2019 when...

With growing focus of governments across the globe on legalising recreational and medicinal cannabis, the cannabis industry is booming at a rapid pace and is expected to offer opportunities for investors. In 2016, Australia became the fourt...

Understanding Penny Stocks Penny stocks are generally priced at below one dollar. However, there can be cases when these stocks can be priced higher than one dollar, depending upon the dilution of issued share capital in the market. Compani...

Stocks trading at a price less than $ 1 are called penny stocks. They are the stocks of small companies and are highly volatile in nature. There is a high level of risk associated with the penny stocks, in addition to higher potential for r...

After what has been a landmark few weeks for Bod Australia which has seen an impressive increase in the Company's value, CEO Jo Patterson jumps on the line to chat through some of Bod's more recent corporate developments.

Medicinal cannabis company Bod Australia (ASX:BDA) says its collaboration with the University of Technology Sydney (UTS) has identified a potential new solution to help guard against the skin aging process.

Australia has established its strong position in the contemporary world that is welcoming the good side of cannabis with open arms, amid the recreational legalising debates. The country joined the bandwagon of Alaska, Canada, North Korea an...

The federal government has taken steps to cut red tape and speed up the granting of licences for Australia’s cannabis players. Health Minister Greg Hunt said the federal government would boost the nation’s medicinal cannabis industry by pri...

Australia is known to have one of the world’s best health system, which provides quality, safe and reasonable healthcare to individuals. This is the reason which places Australia among the countries with the longest life expectancies in the...

Data analytics company Nielsen predicts that the American cannabis market will hit $US41 billion ($59.5 billion) by 2025 — a fivefold increase over 2018. While a good chunk of cannabis products are still illegal in the US, Nielsen reckons s...

Two major cannabis companies Bod Australia (ASX: BDA) and Elixinol (ASX: EXL) have announced partnerships establishing relationships in the United Kingdom. With a growing medicinal cannabis market estimated to be worth $14 billion by 2028...

Amidst the contemplation on the growth of the medicinal cannabis space in Australia, the legalisation of medicinal cannabis is expected to contribute approximately $8.5 million in the nation’s state and federal tax. The utilisation of this...

Bod Australia (ASX: BDA) revealed this morning it has experienced “significant growth” in prescriptions for its medicinal cannabis product, with this growth expected to expand further once numerous applications have been granted. During Jun...

Medicinal cannabis player Althea (ASX: AGH) rejoined the ASX boards today after going into a trading halt last week. And it had some news; a pending $30m capital raising to fund the acquisition of Peak Processing Solutions, a Canadian canna...

A new chain of medical cannabis clinics are set to roll out across Australia as part of a collaboration between Australian biopharma Zelda Therapeutics (ASX:ZLD) and Emerald Clinics. Zelda is developing a new cannabis-based treatment to red...

BOD Australia Ltd [ASX:BDA] has made an agreement with H&H Group’s innovation arm NewH2, which will see NewH2 acquire a small stake in BOD in exchange for a $5.5 million investment. The post BOD Share Price Climbs 45% with New Strategi...

Cannabis-focused healthcare company Bod Australia (ASX: BDA) has struck an exclusive agreement with investment fund NewH2 owned by Hong Kong-listed Health & Happiness Group (H&H). Under the deal, NewH2 will make $5.5 million strateg...

In 2016, Australia legalised cannabis for medicinal and scientific purposes under the Narcotic Drugs Amendment Act 2016. The amendment provided relief to the cannabis sector and enabled the prospective producers to apply for the necessary l...

Investment in defensive stocks seems attractive to some investors as they turn out to be safer during market volatility, although the returns might be lesser than growth stocks. They are less/not affected by economic cycle. Consumer defensi...

Is the world progressing at a pace that it would “go green” when it comes to legalizing of cannabis? The controversy that this topic of taboo holds for the globe is paramount and never-ending; but lately, there has been paradigm shift and a...

Wth the legalisation of medical cannabis in many countries like Canada, the global medical cannabis industry has boomed quite a bit in recent times. Let’s take a quick look at 20 cannabis companies trading on ASX. Cann Group Limited (ASX:...

Do you know that market enthusiasts believe that legalising cannabis would generate approximately $8.5 billion in the country’s federal and state tax? Ponder over the massive revenue that this sector would add to the necessities related to...

Titomic Limited The digital manufacturing solutions company, Titomic (ASX: TTT) is headquartered in Melbourne, Australia, and engaged in the additive manufacturing sector. Its proprietary Titomic Kinetic Fusion™ (TKF) technology is designed...

Listed cannabis healthcare company Bod Australia (ASX: BDA) has teamed up with Burleigh Heads Cannabis (BHC) and partner company Cannabis Doctors Australia (CDA) on a distribution agreement. Under the agreement Bod will gain access to BHC...

Shares in medicinal cannabis company Althea (ASX: AGH) found some demand this morning after a promising development in the UK market. Scroll down for more ASX cannabis news >>> For the first time, a UK patient has been prescribed A...

Up until about four years ago obesity was an ‘it’ investment trend, as global funds spruiked the ‘sugar is the new tobacco’ theme and companies tested treatments specifically targeted at weight loss. Since then the world has not become any...